Diabetes treatment is constantly evolving, with new therapeutic options appearing to improve patient outcomes. Recent investigations have focused on GLP-1 and GIP receptor agonists, a group of drugs that mimic the https://craigzlwx427422.wikimeglio.com/10333493/emerging_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment